Scholars Central

Research articlePublished 31 Jan 2023

A study on intravenous immunoglobulin with and without prednisolone in newly diagnosed pediatric primary immune thrombocytopenia.

Authors: Priyanka Gupta, Sumana Datta, Suprit Basu, Jyotirmoy Sen, Hasibur Rahaman Molla, Subham Bhattacharya, Ahitagni Banerjee

Current Pediatric Research

Volume 27 · Issue 1 · Pages 1765–1769

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction: Immune Thrombocytopenic Purpura (ITP) is an immune-mediated disease characterized by a transient or persistent decrease in the platelet count. First-line agents for treatment include corticosteroids, Intravenous immunoglobulin (IVIG), and anti-D immunoglobulin (anti-D). This study was done to compare the efficacy of IVIG-prednisolone combination therapy with IVIG monotherapy in achieving sustained complete response to newly diagnosed childhood ITP. Methodology: This was a prospective observational study conducted in the department of pediatric medicine in a tertiary care super specialty hospital in Eastern India. Children between 6 months to 12 years with newly diagnosed primary ITP with bleeding and/or platelet count <20,000/cmm were included in the study. The study population was divided into two cohorts: One cohort received IVIG at 0.8 g/kg single dose alone (IVIG cohort) and another one received IVIG in the same dose along with prednisolone 2 mg/kg/day for 14 days followed by quick tapering, maximally over 2 weeks. Both cohorts were followed up for 6 months. Results: Complete Response (CR) was significantly higher in the IVIG-prednisolone cohort, compared to the IVIG cohort. Also, children in IVIG -prednisolone cohort maintained substantially higher median platelet count. The adverse effects in both cohorts were mild and self-limiting. Conclusion: IVIG along with prednisolone as first-line treatment in newly diagnosed pediatric ITP is more efficacious in achieving sustained response and thus, decreasing the chronicity of the disease compared to IVIG monotherapy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Current Pediatric Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCurrent Pediatric Research
  • SubjectPaediatrics & Neonatology
  • BylineArticles whose byline prints “Priyanka Gupta”
  • BylineArticles whose byline prints “Sumana Datta”
  • BylineArticles whose byline prints “Suprit Basu”
  • BylineArticles whose byline prints “Jyotirmoy Sen”
  • BylineArticles whose byline prints “Hasibur Rahaman Molla”
  • BylineArticles whose byline prints “Subham Bhattacharya”
  • BylineArticles whose byline prints “Ahitagni Banerjee”